Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1993-05-06
1995-04-25
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
264 41, 264 43, 4284022, 514 37, 514 78, 514912, 514913, 514914, A61K 9127, A61K 9133
Patent
active
054097045
ABSTRACT:
Aminoglycosides, analogs and derivatives thereof, in the form of phosphate salts are described as well as the process for making and utilizing same. Aminoglycoside phosphate liposomes and nonguanadino aminoglycoside phosphate liposomes, their preparation and use, are particularly described.
REFERENCES:
patent: 498268 (1883-05-01), Janoff et al.
patent: 604503 (1884-05-01), Janoff et al.
patent: 782814 (1885-10-01), Pidgeon
patent: 3962429 (1976-06-01), Furuno et al.
patent: 3993754 (1976-11-01), Rahman et al.
patent: 4016100 (1977-04-01), Suzuki et al.
patent: 4089801 (1978-05-01), Schneider
patent: 4145410 (1979-03-01), Sears
patent: 4193983 (1980-03-01), Ullman et al.
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4370349 (1983-01-01), Evans et al.
patent: 4372949 (1983-02-01), Kodama et al.
patent: 4389330 (1983-06-01), Tice et al.
patent: 4394372 (1983-07-01), Taylor
patent: 4397846 (1983-08-01), Weiner et al.
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4421741 (1983-12-01), Gilbert et al.
patent: 4455296 (1984-06-01), Hansen et al.
patent: 4460577 (1984-07-01), Moro et al.
patent: 4485045 (1984-11-01), Regen
patent: 4515736 (1985-05-01), Deamer
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4529561 (1985-07-01), Hunt et al.
patent: 4532089 (1985-07-01), MacDonald
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4731210 (1988-03-01), Weder et al.
patent: 4897384 (1990-01-01), Janoff et al.
patent: 4975282 (1990-12-01), Cullis et al.
patent: 5030453 (1991-07-01), Lenk et al.
patent: 5059591 (1991-10-01), Janoff et al.
Liposomes, Edited by Marc. J. Ostro, Marcel Dekker, Inc., New York (1983) pp. 70 & 71.
Cecil Textbook of Medicine, 16th Edition, vol. 2, Edited by J. B. Wyngaarden et al., W. B. Saunders Co., Philadelphia (1982), pp. 1432-1435.
Alexander, et al., "Interaction of Aminoglycoside Antibodies with Phospholipid Liposomes Studies by Microelectrophoresis", J. Antibio., 32:504-10 (1979).
Au, et al., "Membrane Perturbation by Aminoglycosides as a Simple Screen of their Toxicity", Antimicrobial Agents and Chemotherapy, 30:395-397 (1986).
Barza, et al., "Pharmacokinetics of subconjunctival Liposome-Encapsulated Gentamicin in Normal Rabbit Eyes", Investigative Ophthlmology & Visual Science, 25: 486-90 (1984).
Carlier, et al., "Inhibition of Lysosomal Phospholipases by Aminoglycoside Antibiotics: In Vitro Comparative Studoies":, Antimicrobial Agents and Chemotherapy, 30: 395-397 (1986).
Chung, et al., "Interaction of Gentamcin and Spermine with Bilayer membranes Containing Negatively Charged Phospholipids", Biochemistry, 24:442-452 (1985).
Dees, et al., :Enhanced Intraphagocytic Killing of Brucella Abortus in Bovine Mononuclear Cells by Liposomes Containing Gentamicin:, Vet. Immunology & Innumophatology 8:171-182 (1985).
Dees, et al. :Evidence for Long Term Survival of Gentamicin in Phagocytic Cells after Insertion by Liposomes, Fed. Proc., 42: Abst 3341 (1983).
Fishmann, et., :"Intravitreal Liposome-Encapsulated Gentamicin in a Rabbit Model", Investigative Ophthalmology & Visual Science, 27: 1103-6 (1986).
Fountain et al: "Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides", & J. Infect. Dis. 1985, 152(3), 529-35.Chemical Abstracts, vol. 103, No. 20, 18th Nov. 1985, p. 368, abstract No. 166095e, Columbus, Ohio, US.
Kaloyanides, et al., "Adsorption of Gentamicin to Liposomes Containing Anionic Phospholipids", Fed. Proc., 42:Abst 3423 (1983).
Kubo, et al., "Binding of Propranolol and Gentamicin to Small Unilamellar Phospholipid Vesicles", Biochemical Pharmacology, 35: 3716-3765 (1986).
Liposomes, ed. Marc J. Ostro, Marcel Dekker, Inc., New York, (1983), pp. 70-71.
Morgan, et al., "Preparation and Properties of Liposome-Associated Gentamicin", Antomicrobial Agents and Chemotherapy, 17:544-548 (1986).
Nagy, et al., "Study in the Subconjunctival Application of Liposomes-Encapsulated Tobramycin", Ann. Immunol. Hung, 25:355-363 (1985).
The Merck Index, Tenth Eddition, Merck & Co., Inc., Rahway, N.J. 1983, p. 1263.
Vladimirskii et al: "Liposome preparations of streptomycin and dihydrostreptomycin", & Antibiotiki (Moscow) 1984, 29(3), 163-6, Chemical Abstracts, vol. 101, No. 2, 9th Jul. 1984, p. 294, abstract No. 12083w, Columbus, Ohio, US.
Abra, et al., 1983, Cancer Chemother. Pharmacol, 11:98, "Delivery of Therapeutic Doses of Doxorubicin in the Mouse Lung Using Lung-Accumulating Liposomes Proves Unsuccessful".
Akerman, et al., 1976, Biochim. Biophys. Acta., 426:624, "Staching of Safranine in Liposomes During Valinomycin Induced Efflux of Potassium Ions".
Bally, et al., 1985, Biochim. Biophys. Acta., 812:66, "Uptake of Saframine and Other Lipophilic Cations into Model Membrane System in Response to a Membrane Potential".
Bonventre, et al., "Killing of Intraphagocytic Straphylococcus aureus by Dihydrostreptomycinl Entrapped Within Liposomes", Antimicrobial Agents and Chemotherapy, 13(6), Jun. 1978, 1049-1051.
Bottcher, et al. 1961 Anal. Chim. Acta., 24:203-204, "A Rapid and Sensitive Sub-Micro Phosphorus Determination".
Brasseur, et al., "Interactions of aminoglycoside antibiotics with negatively charged lipid layers", Biochemical Pharmacology, 33(4):629-637, 1984.
Cafisco, et al., 1983, Biophys, J. 44:49, "Electrogenic H+/OH- Movement Accorss Phospholipid Vesicles Measured by Spin-Labeled Hydrophobic Ions".
Chemical Abstracts 103:174355e.
Chemical Abstracts 99:49240m.
Chen, et al., 1956, Analytical Chem., 11:1756-1758, "Microdetermination of Phosphorus".
Corda, et al., J. Membr. Bio., 1982 65(3) 235-42, "Increase in Lipid Microviscosity of Unilamellar Vesicles upon the Creation of Transmembrane Potential", Chem. Abs. vol. 96, 1982, Abs. 176569p.
Crommelin, et al., 1983, Int. J. Pharm. 16(1):79 "Preparation and Characterization of Doxorubicin-Containing Liposomes: I. Influence of Liposome Charge and pH of Hydration Medium on Loading Capacity and Particle Size".
Deamer, 1983, in: Liposomes, 1983, M. Ostro (ed.), Marcel Dekker, New York pp. 26-57.
Forssen, et al., 1983, Cancer Res., 43:546, "Improved Therapeutic Benefits of Doxorubicin by Entrapment in Anionic Liposomes".
Fountain, et al., "Enhanced Intracellular Killing of Staphylococcus aureus by Canine Monocytess Treated with liposomes Containing Amikacin, Gentamicin, Kanamycin, and Tobramycin", Current Microbiology, 6:373-376, 1981.
Gabizon, et al., 1982, Cancer Res. 42-4734, "Liposomes as in Vivo Carriers of Adriamycin:Reduced Cardiac Uptake and Preserved Antitumor Activity in Mice".
Garcia, et al., 1983, Biochemistry 22(10):2524, "Mechanism of Lactose Translocation in Proteoliposomes Reconstituted with Iac Carrier Protein Purified from Escherichia coli. 1. Effect of pH and Imposed Membrane Potential on Efflux, Exchange, and Counterflow".
Gruner, et al., "Novel Multilayers Lipid Vesicles Comparison of Physical Characteristics of Multilamellar Liposomes and Stable Plurilamellar Vesicles", 1985, Biochem. 24, 2833-2842.
Hodges, et al., "The enhancement of neomycin activity on Escherichia colis by entrapment in liposomes", Chemical Abstracts 92, 1980, Abstr. 92:169154p.
Hope, et., 1985, Biochim. Biophys. Acta., 812:55, "Production of Large Unilamellar Vesciles by a Rapid Extrusion Procedure. Characterization of Size Distribution, Trapped Volume and Ability to Maintain a Membrane Potention".
Jonah, et al., 1975, Biochim, et Biophys. Acta 401:336-348, "Tissue Distribution of EDTA Encapsulated Within Liposomes of Varying Surface Properties".
Kano, et al., 1977, Life Sciences, 20:1729, "Enhanced Uptake of Drugs in Liposomes Use of Labile Vitamin B12 Complexes of 6-Mercaptopurine and 8-Azaguanine".
Kirby, et al., "A Simple Procedure for Preparing Liposomes Capable of high Encapsulation Efficiency Under Mild Consitions", 1984: Liposome Technology, G. Gregoriadis, ed. CRC PRess, Inc., vol. 1, 19-27.
Kirby, et al., 1984, Bio/Technology, 2(11):9
Bally Marcel B.
Bolcsak Lois E.
Cullis Pieter R.
Janoff Andrew S.
Mayer Lawrence D.
Lovering Richard D.
Rubin Kenneth B.
The Liposome Company Inc.
LandOfFree
Liposomes comprising aminoglycoside phosphates and methods of pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposomes comprising aminoglycoside phosphates and methods of pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomes comprising aminoglycoside phosphates and methods of pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1566217